These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 29246661)

  • 1. A quantitative approach to neuropsychiatry: The why and the how.
    Kas MJ; Penninx B; Sommer B; Serretti A; Arango C; Marston H
    Neurosci Biobehav Rev; 2019 Feb; 97():3-9. PubMed ID: 29246661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The reverse translation of a quantitative neuropsychiatric framework into preclinical studies: Focus on social interaction and behavior.
    Peleh T; Ike KGO; Wams EJ; Lebois EP; Hengerer B
    Neurosci Biobehav Rev; 2019 Feb; 97():96-111. PubMed ID: 30660427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative neurosymptomatics: Linking quantitative biology to neuropsychiatry.
    Kas MJ; Serretti A; Marston H
    Neurosci Biobehav Rev; 2019 Feb; 97():1-2. PubMed ID: 30476505
    [No Abstract]   [Full Text] [Related]  

  • 4. The PRISM project: Social withdrawal from an RDoC perspective.
    Cuthbert BN
    Neurosci Biobehav Rev; 2019 Feb; 97():34-37. PubMed ID: 30107226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolving a new neuropsychiatry.
    Fricchione GL
    Dialogues Clin Neurosci; 2018 Jun; 20(2):141-145. PubMed ID: 30250391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of the clinical implementation of a study exploring social withdrawal in patients with schizophrenia and Alzheimer's disease.
    Bilderbeck AC; Penninx BWJH; Arango C; van der Wee N; Kahn R; Winter-van Rossum I; Hayen A; Kas MJ; Post A; Dawson GR
    Neurosci Biobehav Rev; 2019 Feb; 97():87-93. PubMed ID: 29940238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relating constructs of attention and working memory to social withdrawal in Alzheimer's disease and schizophrenia: issues regarding paradigm selection.
    Gilmour G; Porcelli S; Bertaina-Anglade V; Arce E; Dukart J; Hayen A; Lobo A; Lopez-Anton R; Merlo Pich E; Pemberton DJ; Havenith MN; Glennon JC; Harel BT; Dawson G; Marston H; Kozak R; Serretti A
    Neurosci Biobehav Rev; 2019 Feb; 97():47-69. PubMed ID: 30399355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroimaging and psychiatry: the long road from bench to bedside.
    Mayberg HS
    Hastings Cent Rep; 2014; Spec No():S31-6. PubMed ID: 24634083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Social neuroscience: undoing the schism between neurology and psychiatry.
    Ibáñez A; García AM; Esteves S; Yoris A; Muñoz E; Reynaldo L; Pietto ML; Adolfi F; Manes F
    Soc Neurosci; 2018 Feb; 13(1):1-39. PubMed ID: 27707008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Social brain, social dysfunction and social withdrawal.
    Porcelli S; Van Der Wee N; van der Werff S; Aghajani M; Glennon JC; van Heukelum S; Mogavero F; Lobo A; Olivera FJ; Lobo E; Posadas M; Dukart J; Kozak R; Arce E; Ikram A; Vorstman J; Bilderbeck A; Saris I; Kas MJ; Serretti A
    Neurosci Biobehav Rev; 2019 Feb; 97():10-33. PubMed ID: 30244163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perfusion magnetic resonance imaging in psychiatry.
    Théberge J
    Top Magn Reson Imaging; 2008 Apr; 19(2):111-30. PubMed ID: 19363433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical applications of neuropsychological assessment.
    Harvey PD
    Dialogues Clin Neurosci; 2012 Mar; 14(1):91-9. PubMed ID: 22577308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digital behavioural signatures reveal trans-diagnostic clusters of Schizophrenia and Alzheimer's disease patients.
    Kas MJH; Jongs N; Mennes M; Penninx BWJH; Arango C; van der Wee N; Winter-van Rossum I; Ayuso-Mateos JL; Bilderbeck AC; l'Hostis P; Beckmann CF; Dawson GR; Sommer B; Marston HM
    Eur Neuropsychopharmacol; 2024 Jan; 78():3-12. PubMed ID: 37864982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mouse as a model for neuropsychiatric drug development.
    Howe JR; Bear MF; Golshani P; Klann E; Lipton SA; Mucke L; Sahin M; Silva AJ
    Curr Biol; 2018 Sep; 28(17):R909-R914. PubMed ID: 30205056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The science of neuropsychiatry: past, present, and future.
    Arzy S; Danziger S
    J Neuropsychiatry Clin Neurosci; 2014; 26(4):392-5. PubMed ID: 26037864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An International Curriculum for Neuropsychiatry and Behavioural Neurology.
    Sachdev P; Mohan A
    Rev Colomb Psiquiatr; 2017 Oct; 46 Suppl 1():18-27. PubMed ID: 29037334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdiagnostic neurology: neuropsychiatric symptoms in neurodegenerative diseases.
    Husain M
    Brain; 2017 Jun; 140(6):1535-1536. PubMed ID: 28549134
    [No Abstract]   [Full Text] [Related]  

  • 18. Attention.
    Callahan PM; Terry AV
    Handb Exp Pharmacol; 2015; 228():161-89. PubMed ID: 25977082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modern neuroimaging in psychiatry: towards the integration of functional and molecular information.
    Linden D; Thome J
    World J Biol Psychiatry; 2011 Sep; 12 Suppl 1():6-10. PubMed ID: 21905987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advancing drug discovery for neuropsychiatric disorders using patient-specific stem cell models.
    Haggarty SJ; Silva MC; Cross A; Brandon NJ; Perlis RH
    Mol Cell Neurosci; 2016 Jun; 73():104-15. PubMed ID: 26826498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.